{"id":7341,"date":"2019-03-16T07:29:40","date_gmt":"2019-03-16T11:29:40","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=7341"},"modified":"2019-03-16T07:29:40","modified_gmt":"2019-03-16T11:29:40","slug":"new-filings-updated-terms-3-15-19","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-3-15-19\/","title":{"rendered":"New Filings &#038; Updated Terms (3.15.19)"},"content":{"rendered":"<p><!--more--><\/p>\n<p><strong>NEW FILINGS<\/strong><\/p>\n<p>Company: PagerDuty Inc.<br \/>\nSymbol: PD<br \/>\nDescription: PagerDuty acts as the central nervous system for the digital enterprise. PagerDuty harnesses digital signals from virtually any software-enabled system or device, combines it with human response data, and orchestrates teams to take the right actions in real time.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, JP Morgan, RBC Capital, Allen &amp; Co.<br \/>\nCo-Manager(s): KeyBanc Capital, Piper Jaffray, William Blair, BTIG<br \/>\nFiled: 3-15-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Palomar Holdings, Inc.<br \/>\nSymbol: PLMR<br \/>\nDescription: They are a rapidly growing and profitable company focused on the provision of specialty property insurance.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Barclays, JP Morgan, Keefe Bruyette &amp; Woods<br \/>\nCo-Manager(s): Evercore ISI, William Blair, Sandler O&#8217; Neill, SunTrust Robinson Humphrey<br \/>\nFiled: 3-15-19<br \/>\nListed Cash Raise: $50m<\/p>\n<p>Company: Change Healthcare Inc.<br \/>\nSymbol: CHNG<br \/>\nDescription: They are a leading independent healthcare technology platform that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Barclays, Goldman Sachs, JP Morgan<br \/>\nFiled: 3-15-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Jumia Technologies AG<br \/>\nSymbol: JMIA<br \/>\nDescription: They are the leading pan-African e-commerce platform.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Citigroup, Berenberg, RBC Capital<br \/>\nCo-Manager(s): Raymond James Stifel, William Blair<br \/>\nFiled: 3-12-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p><strong>TERMS ADDED<\/strong><\/p>\n<p>Company: Alight Inc<br \/>\nSymbol: ALIT<br \/>\nDescription: Alight is a leading provider of integrated, cloud-based human capital solutions that empower our clients and their employees to manage their health, wealth and HR needs.<br \/>\nShares: 32 million<br \/>\nPrice Range: $22.00-$25.00<br \/>\nTrade Date: 3\/22<br \/>\nUnderwriter(s): BofA Merrill Lynch, JP Morgan, Morgan Stanley,Barclays, BMO, Citigroup, Credit Suisse, Deutsche Bank, Goldman Sachs<br \/>\nCo-Manager(s): Blackstone Capital, CIBC Capital, PNC Capital, Baird, KeyBanc, Macquarie Capital, Stephens, Stifel, Academy Securities, BTIG, Loop Capital, Siebert Cisneros Shank<br \/>\nTerms Added: 3-11-19<\/p>\n<p>Company: Levi Strauss &amp; Co.<br \/>\nSymbol: LEVI<br \/>\nDescription: They design, market and sell products that include jeans, casual and dress pants, tops, shorts, skirts, jackets, footwear and related accessories for men, women and children.<br \/>\nShares: 36.67 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nTrade Date: 3\/21<br \/>\nUnderwriter(s): Goldman Sachs, JP Morgan, BofA Merrill Lynch, Morgan Stanley, Evercore ISI<br \/>\nCo-Manager(s): BNP PARIBAS, Citigroup, Guggenheim Securities, HSBC, Drexel Hamilton, Telsey Advisory Group, The Williams Capital Group<br \/>\nTerms Added: 3-11-19<\/p>\n<p>Company: UP Fintech Holding Limited<br \/>\nSymbol: TIGR<br \/>\nDescription: They are a leading online brokerage firm focusing on global Chinese investors. They are the largest online broker focusing on global Chinese investors in terms of U.S. securities trading volume, with a market share of approximately 58.4% in 2017, according to the iResearch Report.<br \/>\nShares: 13.0 million ADSs<br \/>\nPrice Range: $5.00-$7.00<br \/>\nTrade Date: 3\/20<br \/>\nUnderwriter(s): Citigroup, Deutsche Bank<br \/>\nCo-Manager(s): AMTD, China Merchants Securities, Tiger Brokers<br \/>\nTerms Added: 3-11-19<\/p>\n<p>Company: Genfit S.A.<br \/>\nSymbol: GNFT<br \/>\nDescription: They are a late-stage clinical biopharmaceutical company dedicated to the discovery and development of innovative drug candidates and diagnostic solutions targeting metabolic and liver-related diseases where there is considerable unmet medical need.<br \/>\nShares: 5 million ADSs<br \/>\nPrice Range: $26.33-$26.33<br \/>\nTrade Date: 3\/27<br \/>\nUnderwriter(s): SVB Leerink, Barclays<br \/>\nCo-Manager: Bryan Garnier &amp; Co., Natixis, Roth Capital, HC Wainwright<br \/>\nTerms Added: 3-14-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-7341","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=7341"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7341\/revisions"}],"predecessor-version":[{"id":7342,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7341\/revisions\/7342"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=7341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=7341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=7341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}